32 Participants Needed

Xenon MRI for Detecting Brown Fat in Obesity

KB
RT
Overseen ByRosa Tamara Branca, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Phase 1
Sponsor: University of North Carolina, Chapel Hill
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The primary goal of this study is to evaluate the feasibility of detecting Brown Adipose Tissue (BAT) in healthy subjects by using hyperpolarized xenon gas MRI. In this pilot study, MRI of BAT of healthy adult volunteers will be performed at 3 Tesla to assess image quality using a prototype surface coil and pulse sequence following inhalation of hyperpolarized 129Xe (xenon) gas at thermoneutrality and under mild cold condition. The investigators are testing the abilities of xenon MRI to see brown adipose tissue and detect its thermogenic activity.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking beta blockers.

What data supports the effectiveness of the treatment Xenon MRI for detecting brown fat in obesity?

Research shows that hyperpolarized xenon gas MRI can noninvasively image brown adipose tissue (BAT) in mice, detecting a significant increase in xenon uptake during BAT activation. This suggests that the treatment could effectively identify and measure BAT in both lean and obese subjects, potentially aiding in obesity studies.12345

Is hyperpolarized xenon-129 MRI safe for humans?

Studies have shown that hyperpolarized xenon-129 MRI is generally safe for humans, with protocols ensuring oxygen levels remain stable during imaging. Continuous monitoring and standardized procedures are important to maintain safety during the process.678910

How is the treatment Xenon MRI for detecting brown fat in obesity different from other treatments?

Xenon MRI is unique because it uses hyperpolarized xenon gas to enhance MRI imaging, allowing for detailed visualization of tissues like brown fat, which is not possible with standard imaging techniques. This method leverages the special properties of xenon gas to improve contrast and image quality, offering a novel approach to studying obesity-related changes in the body.1112131415

Research Team

RT

Rosa Tamara Branca, PhD

Principal Investigator

University of North Carolina, Chapel Hill

Eligibility Criteria

This study is for healthy adults over 18 who haven't smoked in the last 5 years and have no lung conditions or history of significant smoking. Participants must be able to hold their breath for at least 15 seconds, not be pregnant or breastfeeding, free from severe claustrophobia, and without any metal implants that could interfere with MRI.

Inclusion Criteria

Smoking history, if any, is less than or equal to 5 pack-years
Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study
I am healthy and may or may not have had a PET scan.
See 5 more

Exclusion Criteria

MRI is contraindicated based on responses to MRI screening questionnaire
Severe claustrophobia
I am under 18 years old.
See 11 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Imaging

Participants undergo MRI scans using hyperpolarized xenon gas to detect brown adipose tissue and its thermogenic activity

1 day
1 visit (in-person)

Follow-up

Participants are monitored for any immediate effects post-MRI scan

1 week

Treatment Details

Interventions

  • Xenon
Trial OverviewThe trial is testing if a special type of MRI using hyperpolarized xenon gas can effectively visualize brown fat tissue in the body under normal and slightly cold conditions. It aims to assess image quality and detect activity within this fat tissue.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Xenon inhalationExperimental Treatment1 Intervention
Inhalation of 5 doses of 750ml of hyperpolarized 129Xe gas

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+

North Carolina Translational and Clinical Sciences Institute

Collaborator

Trials
61
Recruited
4,600+

Findings from Research

A modified MRI protocol successfully visualized and quantified brown adipose tissue (BAT) in laboratory mice, revealing significantly reduced BAT volume in a Huntington disease (HD) model compared to controls (n = 5 per group).
This reduction in BAT volume may explain the energy deficit observed in HD, highlighting the potential of this imaging technique to study BAT in various metabolic disorders and track disease progression.
Two-point magnitude MRI for rapid mapping of brown adipose tissue and its application to the R6/2 mouse model of Huntington disease.Lindenberg, KS., Weydt, P., Müller, HP., et al.[2021]
Xenon-enhanced computed tomography allows for accurate quantification of brown adipose tissue (BAT) mass, even in obese phenotypes where traditional imaging fails.
The method works by using xenon gas to enhance the visibility of BAT during thermogenesis, which is linked to increased blood flow and reduced vascular resistance in the tissue.
Accurate quantification of brown adipose tissue mass by xenon-enhanced computed tomography.Branca, RT., McCallister, A., Yuan, H., et al.[2018]
A new noninvasive imaging technique using hyperpolarized xenon gas MRI allows for the effective measurement of brown adipose tissue (BAT) and its thermogenic function in living mice, overcoming limitations of previous imaging methods.
This technique revealed a significant increase in xenon uptake by BAT during thermogenesis, providing a way to create detailed maps of BAT activity in both lean and obese mice, and enabling direct measurement of BAT temperature to monitor its activity.
Detection of brown adipose tissue and thermogenic activity in mice by hyperpolarized xenon MRI.Branca, RT., He, T., Zhang, L., et al.[2018]

References

Two-point magnitude MRI for rapid mapping of brown adipose tissue and its application to the R6/2 mouse model of Huntington disease. [2021]
Accurate quantification of brown adipose tissue mass by xenon-enhanced computed tomography. [2018]
Detection of brown adipose tissue and thermogenic activity in mice by hyperpolarized xenon MRI. [2018]
MRI characteristics of supraclavicular brown adipose tissue in relation to cold-induced thermogenesis in healthy human adults. [2020]
Measurement of brown adipose tissue mass using a novel dual-echo magnetic resonance imaging approach: a validation study. [2022]
Physiological response of rats to delivery of helium and xenon: implications for hyperpolarized noble gas imaging. [2019]
A thermally polarized 129 Xe phantom for quality assurance in multi-center hyperpolarized gas MRI studies. [2020]
Large production system for hyperpolarized 129Xe for human lung imaging studies. [2022]
Chronic obstructive pulmonary disease: safety and tolerability of hyperpolarized 129Xe MR imaging in healthy volunteers and patients. [2022]
Development of hyperpolarized noble gas MRI. [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
Feasibility of human lung ventilation imaging using highly polarized naturally abundant xenon and optimized three-dimensional steady-state free precession. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Measurement of 129Xe T1 in blood to explore the feasibility of hyperpolarized 129Xe MRI. [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
Brain MRI with laser-polarized 129Xe. [2019]
14.United Statespubmed.ncbi.nlm.nih.gov
Magnetization and diffusion effects in NMR imaging of hyperpolarized substances. [2019]
15.United Statespubmed.ncbi.nlm.nih.gov
In vivo NMR and MRI using injection delivery of laser-polarized xenon. [2023]